The Mechanisms and Implications of Cardiolipin in the Regulation of Cell Death
- PMID: 40103184
- DOI: 10.1002/cbf.70066
The Mechanisms and Implications of Cardiolipin in the Regulation of Cell Death
Abstract
Cardiolipin (CL), an exclusive phospholipid, is predominantly found within the confines of the inner mitochondrial membrane, playing an indispensable role in the sustenance of mitochondrial operations and the regulation of cellular energy metabolism. The influence of CL on the pathways of cell death has garnered significant interest in recent scholarly discourse. This review delves into the multifaceted roles of CL across various modes of cell demise, encompassing apoptosis, autophagy, pyroptosis, ferroptosis, necrosis, and necroptosis. The discussion extends to the examination of CL's implications in a clinical context, particularly concerning cardiovascular maladies, neurological degeneration, and oncological conditions. Through an integrative analysis of contemporary research findings, the aim is to elucidate the intricate dynamics of CL's involvement in cell death phenomena. While acknowledging the inherent limitations and the hurdles faced by current research endeavors, the therapeutic potential of CL as a modulator of cell death pathways is nonetheless encouraging. Forthcoming investigations must surmount these obstacles, thereby uncovering the nuanced mechanisms and impacts of CL in the realm of cell death and associated pathologies, potentially paving the way for innovative clinical intervention strategies.
Keywords: apoptosis; autophagy; cardiolipin; ferroptosis; necroptosis; necrosis; pyroptosis.
© 2025 John Wiley & Sons Ltd.
References
-
- K. Newton, A. Strasser, N. Kayagaki, and V. M. Dixit, “Cell Death,” Cell 187 (2024): 235–256.
-
- F. Dong, J. F. Shang, W. Fang, L. Y. Han, G. L. Lian, and D. Chen, “Research Update on the Role of Necroptosis in the Development and Progression of Cardiovascular Diseases and Related Molecular Mechanisms,” Zhonghua Xin Xue Guan Bing Za Zhi 49 (2021): 728–732.
-
- Y. Hao, Y. Fan, J. Feng, et al., “ALCAT1‐Mediated Abnormal Cardiolipin Remodelling Promotes Mitochondrial Injury in Podocytes in Diabetic Kidney Disease,” Cell Communication and Signaling 22 (2024): 26.
-
- M. Davidescu, L. Mezzasoma, K. Fettucciari, et al., “Cardiolipin‐Mediated Temporal Response to Hydroquinone Toxicity in Human Retinal Pigmented Epithelial Cell Line,” Biochimica et Biophysica Acta (BBA) ‐ Molecular Cell Research 1870 (2023): 119554.
-
- M. Pizzuto and P. Pelegrin, “Cardiolipin in Immune Signaling and Cell Death,” Trends in Cell Biology 30 (2020): 892–903.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
